Matches in Wikidata for { <http://www.wikidata.org/entity/Q57053250> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q57053250 description "article scientifique publié en 2018" @default.
- Q57053250 description "artículu científicu espublizáu n'ochobre de 2018" @default.
- Q57053250 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57053250 description "scientific article published on 01 October 2018" @default.
- Q57053250 description "wetenschappelijk artikel" @default.
- Q57053250 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q57053250 name "Reply to Starting with a lower daily dose of dasatinib in patients with chronic myeloid leukemia in chronic phase: Less is more, or is it?" @default.
- Q57053250 name "Reply to Starting with a lower daily dose of dasatinib in patients with chronic myeloid leukemia in chronic phase: Less is more, or is it?" @default.
- Q57053250 type Item @default.
- Q57053250 label "Reply to Starting with a lower daily dose of dasatinib in patients with chronic myeloid leukemia in chronic phase: Less is more, or is it?" @default.
- Q57053250 label "Reply to Starting with a lower daily dose of dasatinib in patients with chronic myeloid leukemia in chronic phase: Less is more, or is it?" @default.
- Q57053250 prefLabel "Reply to Starting with a lower daily dose of dasatinib in patients with chronic myeloid leukemia in chronic phase: Less is more, or is it?" @default.
- Q57053250 prefLabel "Reply to Starting with a lower daily dose of dasatinib in patients with chronic myeloid leukemia in chronic phase: Less is more, or is it?" @default.
- Q57053250 P1433 Q57053250-53E4E56B-A2EC-468C-A882-E70AFE0B9807 @default.
- Q57053250 P1476 Q57053250-448FBC74-3761-4538-9BB7-C3DE28D7C8F2 @default.
- Q57053250 P2093 Q57053250-50F008A5-F602-42CD-8650-E8BAB6AA20C7 @default.
- Q57053250 P2860 Q57053250-5B352759-85EA-4A5F-8BB5-95F340F875D3 @default.
- Q57053250 P304 Q57053250-90E00D70-B64F-4761-8272-AE6C5FBA8964 @default.
- Q57053250 P31 Q57053250-CD6F90CC-52FF-46B1-8252-945CC1C28BAF @default.
- Q57053250 P356 Q57053250-B5160F55-642A-432D-BA02-478AEFA0E6A2 @default.
- Q57053250 P407 Q57053250-ABABE17E-EA15-4666-97DD-28ABFD3D07DE @default.
- Q57053250 P433 Q57053250-39126EF8-C3EC-4899-9E3F-83910A1490EF @default.
- Q57053250 P478 Q57053250-C698B9A6-6C6C-4485-AAB7-6F09B545A568 @default.
- Q57053250 P50 Q57053250-323BCA51-1193-41E2-BBF1-688C1070275B @default.
- Q57053250 P50 Q57053250-BD1B3F83-0F76-4C4C-A882-45A48F47E3F5 @default.
- Q57053250 P577 Q57053250-BBE6E6A6-B723-45B6-8D47-EC8B99440B2F @default.
- Q57053250 P698 Q57053250-AFC6F5FF-804E-4A3A-BBD6-0025D8793847 @default.
- Q57053250 P921 Q57053250-3AA73EB6-23D5-40C7-A80E-9B3B37B91AC7 @default.
- Q57053250 P921 Q57053250-50AD885F-5A74-441A-91D9-8CDF22CD3ADE @default.
- Q57053250 P921 Q57053250-8F69D127-2118-4783-B2EE-B151749BC014 @default.
- Q57053250 P921 Q57053250-E644F2E8-A138-4805-9424-5746707A9DEC @default.
- Q57053250 P356 CNCR.31683 @default.
- Q57053250 P698 30276797 @default.
- Q57053250 P1433 Q326041 @default.
- Q57053250 P1476 "Reply to Starting with a lower daily dose of dasatinib in patients with chronic myeloid leukemia in chronic phase: Less is more, or is it?" @default.
- Q57053250 P2093 "Kiran Naqvi" @default.
- Q57053250 P2860 Q54979822 @default.
- Q57053250 P304 "4261" @default.
- Q57053250 P31 Q13442814 @default.
- Q57053250 P356 "10.1002/CNCR.31683" @default.
- Q57053250 P407 Q1860 @default.
- Q57053250 P433 "21" @default.
- Q57053250 P478 "124" @default.
- Q57053250 P50 Q60394812 @default.
- Q57053250 P50 Q88556993 @default.
- Q57053250 P577 "2018-10-01T00:00:00Z" @default.
- Q57053250 P698 "30276797" @default.
- Q57053250 P921 Q11688946 @default.
- Q57053250 P921 Q27139135 @default.
- Q57053250 P921 Q419940 @default.
- Q57053250 P921 Q729735 @default.